ArticleJournal of medicinal chemistry2019

Design and Synthesis of Type-IV Inhibitors of BRAF Kinase That Block Dimerization and Overcome Paradoxical MEK/ERK Activation.

Chad M Beneker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.